APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infertility Drugs

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Selected research

Market Analysis & Forecast

Global Infertility Drugs Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchInfertility Drugs Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Infertility Drugs Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Infertility Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infertility Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Infertility Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Global Infertility Drugs key players include LIVZON, Merck, Abbott, Ferring, etc. Global top four manufacturers hold a share about 45%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.

Read the full market overview

In terms of product, Gonadotropins is the largest segment, with a share nearly 80%. And in terms of application, the largest application is Female, followed by Male.

Report Includes

This report presents an overview of global market for Infertility Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Infertility Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Infertility Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Infertility Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Infertility Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Infertility Drugs revenue, projected growth trends, production technology, application and end-user industry.

Infertility Drugs Segment by Company

Merck

Ferring

MSD

LIVZON

Abbott

Bayer Zydus Pharma

Infertility Drugs Segment by Type

Gonadotropins

Anti-Estrogens

Other

Infertility Drugs Segment by Application

Male

Female

Infertility Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infertility Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infertility Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infertility Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Infertility Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Infertility Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Infertility Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Infertility Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gonadotropins Major Player Table 3. Anti-Estrogens Major Player Table 4. Other Major Player Table 5. Global Infertility Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Male Major Player Table 7. Female Major Player Table 8. Infertility Drugs Industry Trends Table 9. Infertility Drugs Industry Drivers Table 10. Infertility Drugs Industry Opportunities and Challenges Table 11. Infertility Drugs Industry Restraints Table 12. Global Infertility Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Infertility Drugs Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Infertility Drugs Market Share by Region (2021-2026) Table 15. Global Infertility Drugs Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Infertility Drugs Market Share by Region (2027-2032) Table 17. Global Infertility Drugs Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Infertility Drugs Revenue Market Share by Players (2021-2026) Table 19. Global Infertility Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Infertility Drugs Key Players Headquarters & Area Served Table 21. Global Infertility Drugs Players, Product Type & Application Table 22. Global Infertility Drugs Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Infertility Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Infertility Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Infertility Drugs Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Infertility Drugs Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Infertility Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Infertility Drugs Revenue Market Share by Type (2027-2032) Table 30. Global Infertility Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Infertility Drugs Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Infertility Drugs Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Infertility Drugs Revenue Market Share by Application (2021-2026) Table 34. Global Infertility Drugs Revenue Market Share by Application (2027-2032) Table 35. Merck Company Information Table 36. Merck Business Overview Table 37. Merck Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Merck Infertility Drugs Product Portfolio Table 39. Merck Recent Development Table 40. Ferring Company Information Table 41. Ferring Business Overview Table 42. Ferring Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Ferring Infertility Drugs Product Portfolio Table 44. Ferring Recent Development Table 45. MSD Company Information Table 46. MSD Business Overview Table 47. MSD Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. MSD Infertility Drugs Product Portfolio Table 49. MSD Recent Development Table 50. LIVZON Company Information Table 51. LIVZON Business Overview Table 52. LIVZON Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. LIVZON Infertility Drugs Product Portfolio Table 54. LIVZON Recent Development Table 55. Abbott Company Information Table 56. Abbott Business Overview Table 57. Abbott Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Abbott Infertility Drugs Product Portfolio Table 59. Abbott Recent Development Table 60. Bayer Zydus Pharma Company Information Table 61. Bayer Zydus Pharma Business Overview Table 62. Bayer Zydus Pharma Infertility Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Bayer Zydus Pharma Infertility Drugs Product Portfolio Table 64. Bayer Zydus Pharma Recent Development Table 65. North America Infertility Drugs Revenue by Type (2021-2026) & (US$ Million) Table 66. North America Infertility Drugs Revenue by Type (2027-2032) & (US$ Million) Table 67. North America Infertility Drugs Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Infertility Drugs Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Infertility Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America Infertility Drugs Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Infertility Drugs Revenue by Country (US$ Million) & (2027-2032) Table 72. Europe Infertility Drugs Revenue by Type (2021-2026) & (US$ Million) Table 73. Europe Infertility Drugs Revenue by Type (2027-2032) & (US$ Million) Table 74. Europe Infertility Drugs Revenue by Application (2021-2026) & (US$ Million) Table 75. Europe Infertility Drugs Revenue by Application (2027-2032) & (US$ Million) Table 76. Europe Infertility Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe Infertility Drugs Revenue by Country (2021-2026) & (US$ Million) Table 78. Europe Infertility Drugs Revenue by Country (US$ Million) & (2027-2032) Table 79. China Infertility Drugs Revenue by Type (2021-2026) & (US$ Million) Table 80. China Infertility Drugs Revenue by Type (2027-2032) & (US$ Million) Table 81. China Infertility Drugs Revenue by Application (2021-2026) & (US$ Million) Table 82. China Infertility Drugs Revenue by Application (2027-2032) & (US$ Million) Table 83. Asia Infertility Drugs Revenue by Type (2021-2026) & (US$ Million) Table 84. Asia Infertility Drugs Revenue by Type (2027-2032) & (US$ Million) Table 85. Asia Infertility Drugs Revenue by Application (2021-2026) & (US$ Million) Table 86. Asia Infertility Drugs Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Infertility Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia Infertility Drugs Revenue by Region (US$ Million) & (2021-2026) Table 89. Asia Infertility Drugs Revenue by Region (US$ Million) & (2027-2032) Table 90. SAMEA Infertility Drugs Revenue by Type (2021-2026) & (US$ Million) Table 91. SAMEA Infertility Drugs Revenue by Type (2027-2032) & (US$ Million) Table 92. SAMEA Infertility Drugs Revenue by Application (2021-2026) & (US$ Million) Table 93. SAMEA Infertility Drugs Revenue by Application (2027-2032) & (US$ Million) Table 94. SAMEA Infertility Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. SAMEA Infertility Drugs Revenue by Country (2021-2026) & (US$ Million) Table 96. SAMEA Infertility Drugs Revenue by Country (US$ Million) & (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Infertility Drugs Image Figure 2. Global Infertility Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infertility Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gonadotropins Image Figure 5. Anti-Estrogens Image Figure 6. Other Image Figure 7. Global Infertility Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Infertility Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Male Image Figure 10. Female Image Figure 11. Global Infertility Drugs Market Size (US$ Million) & (2021-2032) Figure 12. Global Infertility Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Infertility Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Infertility Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Infertility Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Infertility Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Infertility Drugs Revenue Market Share by Type (2021-2032) Figure 19. Global Infertility Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Infertility Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Infertility Drugs Revenue Market Share by Application (2021-2032) Figure 22. North America Infertility Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Infertility Drugs Revenue Share by Type (2021-2032) Figure 24. North America Infertility Drugs Revenue Share by Application (2021-2032) Figure 25. North America Infertility Drugs Revenue Share by Country (2021-2032) Figure 26. United States Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Infertility Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Infertility Drugs Revenue Share by Type (2021-2032) Figure 31. Europe Infertility Drugs Revenue Share by Application (2021-2032) Figure 32. Europe Infertility Drugs Revenue Share by Country (2021-2032) Figure 33. Germany Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Infertility Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Infertility Drugs Revenue Share by Type (2021-2032) Figure 43. China Infertility Drugs Revenue Share by Application (2021-2032) Figure 44. Asia Infertility Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Infertility Drugs Revenue Share by Type (2021-2032) Figure 46. Asia Infertility Drugs Revenue Share by Application (2021-2032) Figure 47. Asia Infertility Drugs Revenue Share by Region (2021-2032) Figure 48. Japan Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Infertility Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Infertility Drugs Revenue Share by Type (2021-2032) Figure 56. SAMEA Infertility Drugs Revenue Share by Application (2021-2032) Figure 57. SAMEA Infertility Drugs Revenue Share by Country (2021-2032) Figure 58. Brazil Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Infertility Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Gonadotropins
  • Anti-Estrogens
  • Other
Applications
  • Male
  • Female
Companies covered
  • Merck
  • Ferring
  • MSD
  • LIVZON
  • Abbott
  • Bayer Zydus Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Infertility Drugs Market by Type
  3. 1.2.1 Global Infertility Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gonadotropins
  5. 1.2.3 Anti-Estrogens
  6. 1.2.4 Other
  7. 1.3 Infertility Drugs Market by Application
  8. 1.3.1 Global Infertility Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Male
  10. 1.3.3 Female
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Infertility Drugs Market Dynamics
  1. 2.1 Infertility Drugs Industry Trends
  2. 2.2 Infertility Drugs Industry Drivers
  3. 2.3 Infertility Drugs Industry Opportunities and Challenges
  4. 2.4 Infertility Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Infertility Drugs Market Perspective (2021-2032)
  2. 3.2 Global Infertility Drugs Growth Trends by Region
  3. 3.2.1 Global Infertility Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Infertility Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Infertility Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Infertility Drugs Revenue by Players
  2. 4.1.1 Global Infertility Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Infertility Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Infertility Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Infertility Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Infertility Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Infertility Drugs Players, Product Type & Application
  8. 4.5 Global Infertility Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Infertility Drugs Market CR5 and HHI
  11. 4.6.3 2025 Infertility Drugs Tier 1, Tier 2, and Tier 3
5 Infertility Drugs Market Size by Type
  1. 5.1 Global Infertility Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Infertility Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Infertility Drugs Revenue Market Share by Type (2021-2032)
6 Infertility Drugs Market Size by Application
  1. 6.1 Global Infertility Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Infertility Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Infertility Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Infertility Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck Infertility Drugs Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Ferring
  8. 7.2.1 Ferring Company Information
  9. 7.2.2 Ferring Business Overview
  10. 7.2.3 Ferring Infertility Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Ferring Infertility Drugs Product Portfolio
  12. 7.2.5 Ferring Recent Developments
  13. 7.3 MSD
  14. 7.3.1 MSD Company Information
  15. 7.3.2 MSD Business Overview
  16. 7.3.3 MSD Infertility Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 MSD Infertility Drugs Product Portfolio
  18. 7.3.5 MSD Recent Developments
  19. 7.4 LIVZON
  20. 7.4.1 LIVZON Company Information
  21. 7.4.2 LIVZON Business Overview
  22. 7.4.3 LIVZON Infertility Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 LIVZON Infertility Drugs Product Portfolio
  24. 7.4.5 LIVZON Recent Developments
  25. 7.5 Abbott
  26. 7.5.1 Abbott Company Information
  27. 7.5.2 Abbott Business Overview
  28. 7.5.3 Abbott Infertility Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Abbott Infertility Drugs Product Portfolio
  30. 7.5.5 Abbott Recent Developments
  31. 7.6 Bayer Zydus Pharma
  32. 7.6.1 Bayer Zydus Pharma Company Information
  33. 7.6.2 Bayer Zydus Pharma Business Overview
  34. 7.6.3 Bayer Zydus Pharma Infertility Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bayer Zydus Pharma Infertility Drugs Product Portfolio
  36. 7.6.5 Bayer Zydus Pharma Recent Developments
8 North America
  1. 8.1 North America Infertility Drugs Revenue (2021-2032)
  2. 8.2 North America Infertility Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Infertility Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Infertility Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Infertility Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Infertility Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Infertility Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Infertility Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Infertility Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Infertility Drugs Revenue by Country
  11. 8.6.1 North America Infertility Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Infertility Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Infertility Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Infertility Drugs Revenue (2021-2032)
  2. 9.2 Europe Infertility Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Infertility Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Infertility Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Infertility Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Infertility Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Infertility Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Infertility Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Infertility Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Infertility Drugs Revenue by Country
  11. 9.6.1 Europe Infertility Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Infertility Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Infertility Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Infertility Drugs Revenue (2021-2032)
  2. 10.2 China Infertility Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Infertility Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Infertility Drugs Revenue by Type (2027-2032)
  5. 10.3 China Infertility Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Infertility Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Infertility Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Infertility Drugs Revenue by Application (2027-2032)
  9. 10.5 China Infertility Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Infertility Drugs Revenue (2021-2032)
  2. 11.2 Asia Infertility Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Infertility Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Infertility Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Infertility Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Infertility Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Infertility Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Infertility Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Infertility Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Infertility Drugs Revenue by Country
  11. 11.6.1 Asia Infertility Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Infertility Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Infertility Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Infertility Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Infertility Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Infertility Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Infertility Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Infertility Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Infertility Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Infertility Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Infertility Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Infertility Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Infertility Drugs Revenue by Country
  11. 12.6.1 SAMEA Infertility Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Infertility Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Infertility Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst